Format and content of applications for agreement or modification of a Paediatric Investigation Plan

AI Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) has released comprehensive guidance regarding the submission of Paediatric Investigation Plans (PIPs) within the United Kingdom. Operating under the regulatory framework of the Human Medicines Regulations 2012 (HMRs), this document details the specific format and content required for applications to agree upon or modify a PIP. It also provides the necessary protocols for requesting waivers and deferrals, which are critical for companies developing new medicinal products. The guidance outlines the specific operations of compliance checks conducted by the agency to ensure adherence to legal standards. While this document is a general regulatory guide and does not name a specific company or list inspection dates and violations, it establishes the mandatory requirements for all pharmaceutical entities. To maintain compliance, applicants must follow the described procedures for UK-PIPs and utilize the MHRA Submissions digital homepage for all related filings. Failure to provide the required data or follow the specified submission format may result in delays or non-compliance during the regulatory review process. Developers are urged to read this in conjunction with the official user reference guides to ensure all technical submission requirements are met.